Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p.

Systemic lupus erythematosus is a prototypic autoimmune disease. Apart from rare monogenic deficiencies of complement factors, where lupuslike disease may occur in association with other autoimmune diseases or high susceptibility to bacterial infections, its etiology is multifactorial in nature. Cutaneous findings are a hallmark of the disease and manifest either alone or in association with internal-organ disease. We describe a novel genodermatosis characterized by painful bluish-red inflammatory papular or nodular lesions in acral locations such as fingers, toes, nose, cheeks, and ears. The lesions sometimes appear plaquelike and tend to ulcerate. Manifestation usually begins in early childhood and is precipitated by cold and wet exposure. Apart from arthralgias, there is no evidence for internal-organ disease or an increased susceptibility to infection. Histological findings include a deep inflammatory infiltrate with perivascular distribution and granular deposits of immunoglobulins and complement along the basement membrane. Some affected individuals show antinuclear antibodies or immune complex formation, whereas cryoglobulins or cold agglutinins are absent. Thus, the findings are consistent with chilblain lupus, a rare form of cutaneous lupus erythematosus. Investigation of a large German kindred with 18 affected members suggests a highly penetrant trait with autosomal dominant inheritance. By single-nucleotide-polymorphism-based genomewide linkage analysis, the locus was mapped to chromosome 3p. Haplotype analysis defined the locus to a 13.8-cM interval with a LOD score of 5.04. This is the first description of a monogenic form of cutaneous lupus erythematosus. Identification of the gene responsible for familial chilblain lupus may shed light on the pathogenesis of common forms of connective-tissue disease such as systemic lupus erythematosus.

[1]  B. Dan,et al.  Phenotypic Overlap between Infantile Systemic Lupus Erythematosus and Aicardi-Goutières Syndrome , 2005, Neuropediatrics.

[2]  W. Wong,et al.  Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese. , 2005, Rheumatology.

[3]  S. Akira,et al.  Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus , 2005, The Journal of experimental medicine.

[4]  R. Copley,et al.  A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity , 2005, Nature.

[5]  L. Lagae,et al.  A second locus for Aicardi-Goutières syndrome at chromosome 13q14–21 , 2005, Journal of Medical Genetics.

[6]  P. Lebon,et al.  Cerebral thrombotic microangiopathy and antiphospholipid antibodies in Aicardi-Goutieres syndrome--report of two sisters. , 2005, Neuropediatrics.

[7]  T. Vyse,et al.  The candidate gene approach: have murine models informed the study of human SLE? , 2004, Clinical and experimental immunology.

[8]  P. Debré,et al.  Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. , 2003, Arthritis and rheumatism.

[9]  S. Rantapää-Dahlqvist,et al.  Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus , 2003, Lupus.

[10]  A. Wilber,et al.  Dnase1l3 deficiency in lupus‐prone MRL and NZB/W F1 mice , 2003, Clinical and experimental immunology.

[11]  C. Woods,et al.  Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism , 2003, Journal of medical genetics.

[12]  K. Nakayama,et al.  Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ , 2002, Nature.

[13]  A. Tarakhovsky,et al.  Protein kinase Cδ controls self-antigen-induced B-cell tolerance , 2002, Nature.

[14]  Lon R. Cardon,et al.  GRR: graphical representation of relationship errors , 2001, Bioinform..

[15]  W. Fridman,et al.  Molecular Basis of a Selective C1s Deficiency Associated with Early Onset Multiple Autoimmune Diseases1 , 2001, The Journal of Immunology.

[16]  K. Takabayashi,et al.  Increased interleukin-17 production in patients with systemic sclerosis. , 2000, Arthritis and rheumatism.

[17]  J. Aicardi,et al.  Systemic Lupus Erythematosus or Aicardi-Goutières Syndrome? , 2000, Neuropediatrics.

[18]  M. Walport Lupus, DNase and defective disposal of cellular debris , 2000, Nature Genetics.

[19]  J. Heckmatt,et al.  Familial Systemic Lupus Erythematosus and Congenital Infection-Like Syndrome , 2000, Neuropediatrics.

[20]  W. Weston,et al.  Childhood Pernio and Cryoproteins , 2000, Pediatric dermatology.

[21]  J. Aicardi,et al.  Aicardi‐Goutières syndrome: An update and results of interferon‐α studies , 1998, Annals of neurology.

[22]  J R O'Connell,et al.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.

[23]  RD Sontheimer The lexicon of cutaneous lupus erythematosus-A review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus , 1997, Lupus.

[24]  J. Tolmie,et al.  The Aicardi-Goutières syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis). , 1995, Journal of medical genetics.

[25]  J. Reveille,et al.  Genetics of systemic lupus erythematosus. , 1992, Rheumatic diseases clinics of North America.

[26]  J. Aicardi,et al.  A Progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis , 1984, Annals of neurology.

[27]  F. Arnett,et al.  Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies. , 1983, Arthritis and rheumatism.

[28]  R. Snyderman,et al.  Deficiency of the fifth component of complement in human subjects: Clinical, genetic and immunologic studies in a large kindred , 1979 .

[29]  S. Lee,et al.  Familial deficiency of two subunits of the first component of complement. C1r and C1s associated with a lupus erythematosus-like disease. , 1978, Arthritis and rheumatism.

[30]  L. Millard,et al.  Chilblain lupus erythematosus (Hutchinson) A CLINICAL AND LABORATORY STUDY OF 17 PATIENTS , 1978, The British journal of dermatology.

[31]  K J Bloch,et al.  Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3. , 1973, The New England journal of medicine.

[32]  J. Hutchinson Harveian Lectures on Lupus , 1888, British medical journal.

[33]  W. Jenner Clinical Lectures on the Diagnosis of Extrapelvic Tumours of the Abdomen , 1869, British medical journal.

[34]  Orphanet Journal of Rare Diseases BioMed Central Review , 2006 .

[35]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[36]  B. Cribier [Chilblain]. , 2001, Annales de dermatologie et de venereologie.

[37]  P. Calzavara-Pinton,et al.  Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. , 1999, Lupus.

[38]  A. Eerenberg-Belmer,et al.  SLE like syndrome and functional deficiency of C1q in members of a large family. , 1984, Clinical and experimental immunology.